Cergutuzumab amunaleukin
ORB1980500
Product group Antibodies
Overview
- SupplierBiorbyt
- Product NameCergutuzumab amunaleukin
- Delivery Days Customer10
- CertificationResearch Use Only
- Concentration5.26 mg/ml
- ConjugateUnconjugated
- Estimated Purity99.7%
- Scientific DescriptionCergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with immunostimulatory and anti-tumor activities for the study of solid cancers.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203